Egetis Therapeutics AB (publ) (EGTX) — Cash Flow-to-Debt Ratio
Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow-to-Debt Ratio of -0.20x as of June 2025, meaning its operating cash flow of Skr-59.00 Million could theoretically repay 0% of its total liabilities (Skr299.30 Million) in one year. See Egetis Therapeutics AB (publ) free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Egetis Therapeutics AB (publ) Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for Egetis Therapeutics AB (publ) across 15 annual periods. Also explore Egetis Therapeutics AB (publ) annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Egetis Therapeutics AB (publ) (2010–2024)
Year-by-year debt coverage analysis for Egetis Therapeutics AB (publ). For market capitalisation and broader financial context, see market value of Egetis Therapeutics AB (publ).
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.76x | Skr-227.90 Million | Skr299.40 Million | ▲ +41.3% |
| 2023 | -1.30x | Skr-278.40 Million | Skr214.60 Million | ▲ +59.0% |
| 2022 | -3.16x | Skr-173.50 Million | Skr54.90 Million | ▼ -2.6% |
| 2021 | -3.08x | Skr-130.11 Million | Skr42.23 Million | ▼ -504.9% |
| 2020 | -0.51x | Skr-134.64 Million | Skr264.34 Million | ▲ +79.5% |
| 2019 | -2.49x | Skr-62.64 Million | Skr25.20 Million | ▲ +29.8% |
| 2018 | -3.54x | Skr-80.31 Million | Skr22.68 Million | ▲ +52.3% |
| 2017 | -7.42x | Skr-86.55 Million | Skr11.66 Million | ▼ -41.3% |
| 2016 | -5.25x | Skr-36.12 Million | Skr6.87 Million | ▲ +55.5% |
| 2015 | -11.82x | Skr-51.15 Million | Skr4.33 Million | ▼ -265.8% |
| 2014 | -3.23x | Skr-41.38 Million | Skr12.81 Million | ▲ +53.3% |
| 2013 | -6.92x | Skr-28.07 Million | Skr4.06 Million | ▼ -41.1% |
| 2012 | -4.90x | Skr-31.96 Million | Skr6.52 Million | ▼ -32.6% |
| 2011 | -3.70x | Skr-14.40 Million | Skr3.89 Million | ▼ -104.5% |
| 2010 | -1.81x | Skr-2.72 Million | Skr1.50 Million | — |